Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR

Abstract Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and has gained considerable global attention. Epidermal growth factor receptor (EGFR) plays a key role in NSCLC treatment. NSCLC with wild-type EGFR (WT-EGFR) is not responsive to EGFR tyrosine kinase...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Peiyuan Sun, Zhuoyi Wang, Ruohan Zhang, Xuanyou Li, Boxing Xu, Rui Shen, Jun Sheng, Jing Wang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-08-01
Subjects:	NSCLC EGFR Cudratricusxanthone A Antitumor Chemosensitivity
Online Access:	https://doi.org/10.1038/s41598-025-14889-x